The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Kabiven emulsion for infusion



Fresenius Kabi LimitedPA0566/003/001

Main Information

Trade NameKabiven emulsion for infusion
Active SubstancesAlanine
Proline
Potassium chloride
Valine
Arginine
Lysine
Threonine
Histidine
Soybean oil
Tyrosine
Magnesium sulfate
Sodium glycerophosphate anhydrous
Phenylalanine
Serine
Tryptophan
Leucine
Aspartic acid
Calcium chloride
Glycine hydrochloride
Glucose anhydrous
Sodium acetate
Isoleucine
Glutamic acid
Methionine
Dosage FormEmulsion for infusion
Licence HolderFresenius Kabi Limited
Licence NumberPA0566/003/001

Group Information

ATC CodeB05BA Solutions for parenteral nutrition
B05BA10 combinations

Status

License statusWithdrawn
Withdrawn Date27/11/2018
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back